NCT07773805

Brief Summary

This randomized clinical trial aims to compare the clinical and radiographic success of calcium hydroxide-iodoform paste and modified triple antibiotic paste when used for the treatment of necrotic primary molars in children using the lesion sterilization and tissue repair (LSTR) technique. The study will include children aged 4-7 years with restorable necrotic mandibular second primary molars. Participants will be randomly assigned to receive LSTR treatment with either calcium hydroxide-iodoform paste or modified triple antibiotic paste. Clinical and radiographic findings will be assessed during follow-up over 12 months to determine the success of each treatment. The study hypothesis is that there will be a difference in the clinical and radiographic success between the two treatment materials when used with the LSTR technique

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
12mo left

Started Jan 2027

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 16, 2026

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 19, 2026

Completed
5 months until next milestone

Study Start

First participant enrolled

January 1, 2027

Expected
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2028

Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2028

Last Updated

August 19, 2026

Status Verified

August 1, 2026

Enrollment Period

1 year

First QC Date

August 16, 2026

Last Update Submit

August 16, 2026

Conditions

Keywords

Lesion Sterilization and Tissue RepairDental Pulp NecrosisCalcium Hydroxide-Iodoform PasteModified Triple Antibiotic PasteNecrotic Primary Teeth

Outcome Measures

Primary Outcomes (4)

  • Pathological Mobility

    Tooth mobility will be assessed using Miller's Mobility Index, ranging from Grade 0 to Grade 3. Grade 0 indicates no clinically detectable mobility, while Grade 1 indicates slight horizontal mobility, Grade 2 indicates moderate horizontal mobility, and Grade 3 indicates severe mobility with both horizontal and vertical displacement. Higher grades indicate greater severity of pathological tooth mobility

    Baseline (pre-operative), 3 months post-operative, 6 months post-operative, 9 months post-operative, 12 months post-operative

  • Soft Tissue Pathologies

    Soft tissue pathologies will be assessed clinically by visual examination for the presence or absence of swelling, abscess, sinus tract, or fistula associated with the treated tooth. Each finding will be recorded as present or absent

    Baseline (pre-operative), 3 months post-operative, 6 months post-operative, 9 months post-operative, 12 months post-operative

  • Pain on Percussion

    Pain on percussion will be assessed clinically using a percussion test of the treated tooth. The response will be recorded as binary, indicating whether pain on percussion is present or absent.

    Baseline (pre-operative), 3 months post-operative, 6 months post-operative, 9 months post-operative, 12 months post-operative

  • Postoperative Pain

    Postoperative pain will be assessed by verbally questioning the participant regarding the presence of pain following treatment. The response will be recorded as binary, indicating whether postoperative pain is present or absent

    Baseline (pre-operative), 3 months post-operative, 6 months post-operative, 9 months post-operative, 12 months post-operative

Secondary Outcomes (2)

  • Radiolucency at the periapical or furcation area

    Baseline (pre-operative), 3 months post-operative, 6 months post-operative, 9 months post-operative, 12 months post-operative

  • Internal or External Root Resorption

    Baseline (pre-operative), 3 months post-operative, 6 months post-operative, 9 months post-operative, 12 months post-operative

Study Arms (2)

Calcium Hydroxide-Iodoform Paste + LSTR

EXPERIMENTAL

Participants assigned to this arm will receive lesion sterilization and tissue repair (LSTR) treatment using calcium hydroxide-iodoform paste as the antimicrobial material. The treatment will be performed according to the standardized clinical protocol, followed by clinical and radiographic evaluation during the 12-month follow-up period.

Drug: Calcium Hydroxide, Iodoform, paste

Modified Triple Antibiotic Paste + LSTR

ACTIVE COMPARATOR

Participants assigned to this arm will receive lesion sterilization and tissue repair (LSTR) treatment using modified triple antibiotic paste as the antimicrobial material. The treatment will be performed according to the standardized clinical protocol, followed by clinical and radiographic evaluation during the 12-month follow-up period.

Drug: modified triple antibiotic paste

Interventions

Calcium hydroxide-iodoform paste will be used as the antimicrobial material for lesion sterilization and tissue repair (LSTR) treatment of necrotic primary molars. Following access to the pulp chamber and the clinical procedures specified in the study protocol, the paste will be placed into the prepared pulp chamber/canal orifices according to the standardized LSTR technique. The tooth will then be restored according to the study protocol. Participants will undergo clinical and radiographic follow-up for 12 months to assess treatment success.

Calcium Hydroxide-Iodoform Paste + LSTR

Modified triple antibiotic paste will be used as the antimicrobial material for lesion sterilization and tissue repair (LSTR) treatment of necrotic primary molars. The paste will be prepared and applied according to the standardized formulation and clinical protocol specified in the study. Following access to the pulp chamber and the clinical procedures specified in the study protocol, the paste will be placed according to the LSTR technique. The tooth will then be restored according to the study protocol. Participants will undergo clinical and radiographic follow-up for 12 months to assess treatment success.

Modified Triple Antibiotic Paste + LSTR

Eligibility Criteria

Age4 Years - 7 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Pediatric patients aged 4-7 years
  • Positive parental informed consent
  • Restorable necrotic mandibular second primary molars with peri-radicular/furcal involvement and/or pathologic root resorption (external or internal one-third to two-thirds of the root)
  • Presence of chronic apical abscess or sinus tract or furcation radiolucency

You may not qualify if:

  • Medically compromised patient
  • Children with a known allergy to any of the components being utilized
  • Molars near exfoliation
  • Molars with severely resorbed roots more than two thirds, indicated for extraction
  • Molar with insufficient coronal structure disabling proper coronal seal
  • Presence of a periapical or interradicular radiolucent area which could compromise the permanent tooth bud

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (20)

  • Almarji W, Laflouf M, Tolibah YA. Evaluation of the modified 3Mix-Simvastatin combination in non-instrumental endodontic therapy of necrotic primary molars: A two-arm randomized controlled trial. Clin Exp Dent Res. 2024 Apr;10(2):e860. doi: 10.1002/cre2.860.

    PMID: 38433296BACKGROUND
  • Thakur S, Deep A, Singhal P, Chauhan D. A randomized control trial comparing the efficacy of 3Mixtatin and Modified 3Mix-MP paste using lesion sterilization and tissue repair technique to conventional root canal treatment in primary molars of children aged 4-8 years: An in vivo study. Dent Res J (Isfahan). 2021 Nov 22;18:93. doi: 10.4103/1735-3327.330874. eCollection 2021.

    PMID: 35003558BACKGROUND
  • Singh K, Reddy A, Arya A, Sridhar V, Ranjan M, Bulbule N. Lesion Sterilization Tissue Repair: A Review. J Pharm Bioallied Sci. 2024 Feb;16(Suppl 1):S75-S77. doi: 10.4103/jpbs.jpbs_411_23. Epub 2024 Feb 29.

    PMID: 38595433BACKGROUND
  • Shafi MK, Shah AA, Khan MA, Faisal S, Iqbal S. The Assessment and Efficiency of Cefixime in Upper Respiratory Tract Infections: Insights and Perspectives. Cureus. 2024 Jul 14;16(7):e64539. doi: 10.7759/cureus.64539. eCollection 2024 Jul.

    PMID: 39144897BACKGROUND
  • Sain S, J R, S A, George S, S Issac J, A John S. Lesion Sterilization and Tissue Repair-Current Concepts and Practices. Int J Clin Pediatr Dent. 2018 Sep-Oct;11(5):446-450. doi: 10.5005/jp-journals-10005-1555. Epub 2018 Oct 1.

    PMID: 30787561BACKGROUND
  • Sefa I, Garg N, Pathivada L, Yeluri R. Success of Lesion Sterilization and Tissue Repair Therapy and Pulpectomy in the Management of Infected Primary Molars with Poor Prognosis. Int J Clin Pediatr Dent. 2024 Jan;17(1):41-47. doi: 10.5005/jp-journals-10005-2750.

    PMID: 38559868BACKGROUND
  • Shankar K, Ramkumar H, Dhakshinamoorthy S, Paulindraraj S, Jayakaran TG, Bommareddy CS. Comparison of Modified Triple Antibiotic Paste in Two Concentrations for Lesion Sterilization and Tissue Repair in Primary Molars: An In Vivo Interventional Randomized Clinical Trial. Int J Clin Pediatr Dent. 2021 May-Jun;14(3):388-392. doi: 10.5005/jp-journals-10005-1951.

    PMID: 34720512BACKGROUND
  • M Ghorpad, T. (2024). Success Rate of Triple Antibiotic Paste for Lesion Sterilization and Tissue Repair Therapy in Primary Molars: A Systematic Review. World Journal of Dentistry, 14(12).

    BACKGROUND
  • Li L, Yang X, Ju W, Li J, Yang X. Impact of primary molars with periapical disease on permanent successors: A retrospective radiographic study. Heliyon. 2023 Apr 28;9(5):e15854. doi: 10.1016/j.heliyon.2023.e15854. eCollection 2023 May.

    PMID: 37187910BACKGROUND
  • Govindaraju L, Jeevanandan G, Vishwanathaiah S, Maganur PCG. Clinical and radiographic success rate of the root canal filling materials used in primary teeth: A systematic review. Dent Med Probl. 2024 May-Jun;61(3):447-455. doi: 10.17219/dmp/152235.

    PMID: 38963396BACKGROUND
  • Estrela C, Estrela CR, Hollanda AC, Decurcio Dde A, Pecora JD. Influence of iodoform on antimicrobial potential of calcium hydroxide. J Appl Oral Sci. 2006 Jan;14(1):33-7. doi: 10.1590/s1678-77572006000100007.

    PMID: 19089027BACKGROUND
  • Barve A, Lakade L, Shah P, Chaudhary S, Jajoo S, Joshi G. Antibiotic Paste as an Intracanal Medicament in Infected Primary Teeth: A Systematic Review. Cureus. 2025 Apr 23;17(4):e82876. doi: 10.7759/cureus.82876. eCollection 2025 Apr.

    PMID: 40416098BACKGROUND
  • Amila Zukanović, Elmedin Bajrić, Marković, N., Damir Duratbegović, Katana, E., Emina Čengić, Senka Serhatlić and Hasan Pejak (2023). Lesion sterilization and tissue repair (LSTR) method in irreversible dental pulp changes of primary teeth. Balkan Journal of Dental Medicine, 27(1), pp.15-20. doi:10.5937/bjdm2301015z.

    BACKGROUND
  • Alrayes N, Almaimouni Y, Tounsi A, Tarabzouni K, Alonaizan F, Salem Ibrahim M. The effect of an antibacterial mixture and non-instrumentation endodontic treatment in primary teeth: A systematic review and meta-analyses. Saudi Dent J. 2023 Sep;35(6):575-588. doi: 10.1016/j.sdentj.2023.06.001. Epub 2023 Jun 19.

    PMID: 37823084BACKGROUND
  • ali, I., Mohamed Ismai, A. A. D., Abbas, A. (2022). 'Clinical and Radiographic Evaluation of Different Obturating Materials as Biological Barrier in Quality of Obturation of Pulpectomized Primary Anterior Teeth', Al-Azhar Journal of Dental Science, 25(4), pp. 505-515. doi: 10.21608/ajdsm.2022.119687.1301

    BACKGROUND
  • Ahuja, V., Ahuja, A., Verma, J., & Arunima. (2021). Apexification with apical growth and closure using Metapex in a Necrotic Immature Permanent Tooth with Periapical abscess: A Case Report with 16 months follow-up . UNIVERSITY JOURNAL OF DENTAL SCIENCES, 7(1). https://doi.org/10.21276/10.21276/ujds.2021.7.1.26

    BACKGROUND
  • Khadilkar AS, Kapur A, Goyal A, Gauba K, Singh SK. Comparison of clinical performance of obturating materials in pulpectomies: A randomized clinical trial. J Indian Soc Pedod Prev Dent. 2024 Jan 1;42(1):28-36. doi: 10.4103/jisppd.jisppd_516_23. Epub 2024 Apr 15.

  • Baghlaf K, Alamoudi RA. Clinical and radiographic success of lesion sterilization and tissue repair in primary teeth: a systematic review and meta-analysis. Saudi Dent J. 2025 Oct 15;37(7-9):61. doi: 10.1007/s44445-025-00059-2.

  • Agarwal SR, Bendgude VD, Kakodkar P. Evaluation of Success Rate of Lesion Sterilization and Tissue Repair Compared to Vitapex in Pulpally Involved Primary Teeth: A Systematic Review. J Conserv Dent. 2019 Nov-Dec;22(6):510-515. doi: 10.4103/JCD.JCD_76_20. Epub 2020 Aug 20.

  • Achanta A, Reche A, Dakhale R, Bharate RR. A Comprehensive Review of Lesion Sterilization and Tissue Repair: An Alternative for Pulpectomy in Deciduous Teeth. Cureus. 2023 Nov 3;15(11):e48218. doi: 10.7759/cureus.48218. eCollection 2023 Nov.

MeSH Terms

Conditions

Dental Pulp NecrosisPeriapical DiseasesDental Caries

Interventions

Calcium HydroxideiodoformOintments

Condition Hierarchy (Ancestors)

Dental Pulp DiseasesTooth DiseasesStomatognathic DiseasesNecrosisPathologic ProcessesPathological Conditions, Signs and SymptomsJaw DiseasesPeriodontal DiseasesMouth DiseasesTooth Demineralization

Intervention Hierarchy (Ancestors)

HydroxidesAlkaliesInorganic ChemicalsCalcium CompoundsAnionsIonsElectrolytesDosage FormsPharmaceutical Preparations

Study Officials

  • Prof.Dr.Rania Abdullah Nasr, PhD

    Faculty of dentistry , Cairo university , Cairo , Giza , Egypt , 12613

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Yasmine Gamal Hafez Dawood Ghazaly, B.D.S faculty of dentistry

CONTACT

Prof.Dr.Osama EL Shahawy Chief supervisor, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Participants and outcome assessors will be blinded to treatment allocation. The care provider administering the intervention will not be blinded because knowledge of the assigned treatment material is required for treatment administration
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This is a prospective, parallel-group, randomized clinical trial with a 1:1 allocation ratio. Participants will be randomly assigned to one of two treatment groups and followed prospectively for 12 months.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Master's Student, Department of Pediatric Dentistry

Study Record Dates

First Submitted

August 16, 2026

First Posted

August 19, 2026

Study Start (Estimated)

January 1, 2027

Primary Completion (Estimated)

January 1, 2028

Study Completion (Estimated)

January 1, 2028

Last Updated

August 19, 2026

Record last verified: 2026-08

Data Sharing

IPD Sharing
Will not share